Investigating how mTOR activation in brain cells may prevent epilepsy
Anti-epileptogenic role of mTOR activation among hippocampal interneurons
This study is looking at how a specific pathway in the brain might help prevent epilepsy by activating certain brain cells, and it could lead to new treatments that help people with epilepsy in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10989968 on NIH RePORTER |
What this research studies
This research explores the role of the mTOR pathway in preventing epilepsy, a condition that currently has no effective preventative treatments. The study focuses on how activating mTOR in specific brain cells, particularly GABAergic interneurons, may help counteract the development of epilepsy. By using advanced genetic techniques, researchers aim to understand the dual role of mTOR in excitatory and inhibitory neurons, which could lead to new therapeutic strategies. Patients may benefit from insights that could lead to innovative treatments for epilepsy.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of seizures or those at high risk for developing epilepsy.
Not a fit: Patients who have already developed epilepsy and are not at risk for further progression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventative therapies for epilepsy, improving outcomes for patients at risk.
How similar studies have performed: Previous research has shown promise in targeting the mTOR pathway for epilepsy treatment, suggesting potential for success in this approach.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Danzer, Steve C — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Danzer, Steve C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.